Akebia Therapeutics (AKBA) Earnings (2013 - 2026)
Akebia Therapeutics (AKBA) earnings from Mar 31, 2013 to Mar 31, 2026. The TTM Akebia Therapeutics (AKBA) earnings is -$21M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Akebia Therapeutics (AKBA) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -54.76% |
| 3 Years TTM | -28.44% |
| 5 Years TTM | -26.54% |
| 10 Years TTM | -12.26% |
| All Time TTM | -0.68% |
Annual Earnings change of Akebia Therapeutics (AKBA)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$9.05M | +69.48% |
| 2025 | -$5.34M | -92.31% |
| 2024 | -$69M | +33.69% |
| 2023 | -$52M | -43.91% |
| 2022 | -$93M | -67.27% |
| 2021 | -$283M | +225.10% |
| 2020 | -$87M | -68.89% |
| 2019 | -$280M | +94.76% |
| 2018 | -$144M | +94.91% |
| 2017 | -$74M | -45.73% |
| 2016 | -$136M | +123.57% |
| 2015 | -$61M | +63.98% |
| 2014 | -$37M | +181.17% |
| 2013 | -$13M | +60.61% |
| 2012 | -$8.20M | N/A |
Comparison Akebia Therapeutics (AKBA) five years earnings CAGR with competitors
Akebia Therapeutics (AKBA) five years earnings CAGR is -26.53%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 99.69% | -475.74% |
| TLRY | Tilray Brands Inc | 57.78% | -317.75% |
| PRGO | Perrigo Company plc | 51.08% | -292.53% |
| RGC | Regencell Bioscience Holdings Ltd | 34.56% | -230.27% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | -206.97% |
| UTHR | United Therapeutics Corp | 26.00% | -197.99% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | -181.64% |
| AYTU | Aytu BioPharma Inc | 21.24% | -180.07% |
| PAHC | Phibro Animal Health Corp - Class A | 17.29% | -165.16% |
| BCRX | Biocryst Pharmaceuticals Inc | 16.93% | -163.82% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | -144.58% |
| NBIX | Neurocrine Biosciences Inc | 10.71% | -140.37% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | -139.33% |
| ZTS | Zoetis Inc - Class A | 8.54% | -132.17% |
| KMDA | Kamada Ltd | 6.87% | -125.89% |
| PRFX | PRF Technologies Ltd | 6.09% | -122.95% |
| AQST | Aquestive Therapeutics Inc | 5.03% | -118.95% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | -114.13% |
| CPHI | China Pharma Holdings Inc | 3.58% | -113.50% |
| BHC | Bausch Health Companies Inc | 3.48% | -113.12% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -111.06% |